Lunit Wins Government Tender from France's Largest Public Healthcare Procurement Group "UniHA"

On September 11, Lunit, a medical artificial intelligence (AI) company, announced that it has been selected as a supplier in the breast cancer diagnosis AI solution tender by UniHA, the largest public hospital purchasing cooperative in France.

UniHA is the largest public healthcare purchasing cooperative in France, responsible for procuring medical equipment for more than 1,500 public hospitals and over 130 regional hospital groups. This tender was conducted for the joint purchase of AI solutions to be used in breast cancer screening at member hospitals.

Through this contract, Lunit's mammography AI solution "Lunit INSIGHT MMG," its 3D breast tomosynthesis AI solution "Lunit INSIGHT DBT," as well as its subsidiary Volpara's mammography image quality management solution "Volpara Analytics" and real-time image quality feedback solution "Volpara Live," have all been listed in the product catalog. As a result, UniHA member hospitals can now adopt Lunit Group's solutions directly through the global medical imaging equipment manufacturer Fujifilm, without the need for separate tender procedures.

Bertrand Lepage, Head of the Biomedical Program at UniHA, stated, "As demand for mammography AI solutions has increased among medical institutions within our network, we conducted a tender applying strict technical standards," adding, "Our goal is to ensure that public medical institutions can introduce top-level technologies under the same conditions as private hospitals."

Seo Beomseok, CEO of Lunit, commented, "This contract has secured us the opportunity to supply our AI solutions on a large scale to public hospitals across France," and added, "Being selected in such a highly competitive tender together with our long-term partner Fujifilm is proof of the overwhelming technological capabilities of Lunit and Volpara in the field of breast cancer screening, and it marks an important achievement in solidifying our position in the core public market of Europe."

In fact, there has been positive feedback from hospitals in France currently using the solutions. Eric Kamus, a radiologist at Lille University Hospital, a UniHA member institution, said, "I have been practicing breast imaging since the 1980s, and Lunit AI serves as a reliable tool that always maintains high concentration and accuracy without fatigue," adding, "It helps medical staff maintain focus in both high-volume private clinics and busy university hospitals."

Meanwhile, Lunit has designated France as a key global market and has been actively targeting it. The UniHA contract is expected to be a major turning point in entering the French public healthcare market. As individual hospitals can now adopt Lunit's solutions without complex tender processes, rapid expansion across France is anticipated. Lunit plans to leverage this achievement to further expand its influence throughout the entire European public market.

This content was produced with the assistance of AI translation services.